2022-01-17| Partner

Digital Health Programme to Connect British and Taiwanese Leaders

by Joy Lin
Share To

Taiwan’s digital health industry, powered by its state-of-the-art ICT sector, presents an exciting opportunity for overseas investment and collaboration. The British Office Taipei, in collaboration with GeneOnline, is arranging an exclusive webinar only for UK businesses and matchmaking events for both UK and Taiwan businesses in ICT, VC, medical AloT, Medtech, digital health and research to identify prospective partners. 


The Key Strengths of Taiwan’s Digital Health


Taiwan is more known for its semiconductors, less so for its digital health industry. Both are, in fact, two sides of the same coin, powered by Taiwan’s state-of-the-art information and communications technology (ICT). 

The island is constantly exploring ways to incorporate ICT into the healthcare sector, and reimagining how healthcare providers can offer services. 

As a result, digital health has taken off, spawning mobile apps that could test for COVID-19, artificial applications that could aid physicians with detecting diseases such as cancer, and more.

Taiwan’s advancements in digital health have attracted international attention. The UK and Taiwan could share complementary strengths in digital health and medical AloT, have similar public health structures and have geographical proximity to the larger APAC region. 

An exclusive webinar and B2B Matchmaking for the UK businesses and academia will offer them an opportunity to connect with Taiwanese companies for future collaboration. 


Understanding the Forces Driving Taiwan’s Healthcare 


The 2022 UK-Taiwan Digital Health Webinar held on February 10 will offer valuable insights about Taiwan’s market and regulatory landscape, which, along with matchmaking events, explore areas of joint interest, research, and links to commercial partners in Taiwan. It will cover three main topics: 

  • Taiwan’s Healthcare System 

  • The Digital Health Market Landscape

  • An Overview of the Regulatory Environment


The 2022 UK-Taiwan Digital Health Programme Webinar Agenda


“Introduction of Taiwan’s Healthcare System” will be presented by Marc Min-Huei Hsu, Dean of the Office of Data Science at Taipei Medical University and former head of the Department of Information Management at the Ministry of Health and Welfare. 

Besides detailing the healthcare system and state of patient care in Taiwan, Hsu will also outline the uptake of digital innovations with healthcare providers such as hospitals. 

Next, Brian Chong, Vice President of Wistron Medical Technology, will present on the topic “Introducing the Digital Health Market in Taiwan”.

Chong will give an overview of Taiwan’s digital health market, covering key strengths and emphasizing unmet market needs and opportunities.  

The last topic “An Overview of the Regulatory Environment in Taiwan” will be discussed by Jarret Su, Co-Head of Healthcare & Life Science, KPMG in Taiwan.

Su will focus on the regulatory aspects of digital health in Taiwan, and highlight the opportunities and challenges in entering the industry. 

Following the webinar, the B2B Matchmaking held on March 7- 11 allows selected organisations in ICT, VC, Medical AIoT, MedTech, digital health, and research to identify prospective partners and create sustainable collaboration with the 1-1 partnering platform in real-time.


Registering for Webinar and Matchmaking Today


The webinar: February 10, from 8:30-10:00 (GMT)

The B2B Matchmaking: March 7-11 

The 2022 UK-Taiwan Digital Health Programme

For more information and to register, please click here.

For enquiries, please contact Sarah Wang ( or Guinnevere Sung (

© All rights reserved. Collaborate with us:
Related Post
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
Genetics May Be a Factor in Varying COVID-19 Severity
ASEAN Health Officials to Establish Regional CDC Following COVID-19
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
Stanford Touts Remote-Controllable CAR-T Cell Therapy
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
ASCO Annual Meeting
Online and on-side
Digital RESI June
BIO International Convention
San Diego, CA
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!